Approvals· May 10, 2026 · 4 min read
Orange Book vs Purple Book: the launch-team read that prevents bad assumptions
Orange Book and Purple Book answer different regulatory questions. Mixing them up creates bad generic, biosimilar, exclusivity, and substitution assumptions.
By Ran Chen#Orange Book#Purple Book#FDA Approval